MeSH term
Frequency | Condition_Probility | Animals | 23 | 0.0 |
Female | 10 | 0.0 |
Gene Expression | 4 | 0.0 |
Humans | 41 | 0.0 |
Male | 8 | 0.0 |
Mice | 11 | 0.0 |
Mutation | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Base Sequence | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Thymus Gland/metabolism | 2 | 2.0 |
Adolescent | 3 | 0.0 |
Adult | 3 | 0.0 |
Child | 3 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
DNA-Binding Proteins/genetics/physiology | 2 | 2.0 |
COS Cells | 3 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Transfection | 4 | 0.0 |
U937 Cells | 2 | 0.0 |
Alleles | 2 | 0.0 |
Diabetes Mellitus, Type 1/*genetics | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
HLA-DQ Antigens/genetics | 2 | 0.0 |
Haplotypes | 4 | 0.0 |
Models, Genetic | 4 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Chromosome Mapping/*methods | 2 | 1.0 |
Transcription Factors/*genetics | 6 | 0.0 |
English Abstract | 3 | 0.0 |
Models, Animal | 2 | 0.0 |
Phenotype | 3 | 0.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Transcription Factors/genetics | 5 | 0.0 |
Cell Line | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Mutation, Missense/genetics | 2 | 1.0 |
Transcription Factors/chemistry/*genetics/*metabolism | 2 | 7.0 |
Autoimmunity/*genetics | 3 | 21.0 |
Cloning, Molecular | 4 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Cell Nucleus/chemistry | 2 | 1.0 |
Cytoplasm/chemistry | 2 | 1.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Pedigree | 2 | 0.0 |
Polyendocrinopathies, Autoimmune/*genetics | 5 | 33.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Zinc Fingers/genetics | 3 | 1.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Recombinant Fusion Proteins/genetics | 2 | 1.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Italy | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Autoantibodies/blood | 2 | 1.0 |
RNA, Messenger/analysis | 3 | 0.0 |
*Self Tolerance | 2 | 20.0 |
Gene Expression Profiling | 2 | 0.0 |
